Iovance Biotherapeutics, Inc. IOVA FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s FX effect on cash?
- Iovance Biotherapeutics, Inc. (IOVA) reported FX effect on cash of -$213K in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s FX effect on cash changed year-over-year?
- Iovance Biotherapeutics, Inc.'s FX effect on cash decreased by 141.9% year-over-year, from $508K to -$213K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.